Follow the Money: Potential Best-in-Category Weight Loss Drug Tubulis’ ADC Advancement, Trojan Horse Treatment for Cancer

<div><p paraid=”454027954″ paraeid=”{0e32d266-aad9-450c-88d2-3ac9efdbcc89}{11}”><strong>By Bio-IT World Staff </strong></p></div><div><p paraid=”1921903147″ paraeid=”{0e32d266-aad9-450c-88d2-3ac9efdbcc89}{17}”><strong>October 28, 2025</strong> | Kailera Therapeutics advances injectable dual GLP-1/GIP receptor agonist; Tubulis develops antibody-drug conjugate for ovarian cancer and lung adenocarcinomas; Trogenix advances their pipeline of potentially curative cancer therapies across multiple aggressive solid tumors into the clinic; and more. </p><div><p paraid=”258675378″ paraeid=”{0e32d266-aad9-450c-88d2-3ac9efdbcc89}{149}”><strong>$600M: Series B for Obesity Treatment </strong></p></div><div><p […]

McDonald’s has a big customer problem on hands

McDonald’s is one of the most popular restaurants in the world, but the company has been witnessing a troubling shift in customer behavior lately as the economy strains many of its customers, forcing them to reduce their visits. Customers can’t be blamed, given that prices across the quick-service restaurant (QSR) industry have risen sharply, making […]

How does front end innovation work at Givaudan? In conversation with Alexandre Bastos

What is “front-end innovation” and how is it structured at global flavors and fragrances giant Givaudan? “Our teams can [assess] one [startup] here and another there, but the 1,000 companies we see every year, it’s more coming from accelerators, VC investors and other scouters that are out there looking for our needs,” says Alexandre Bastos, […]